Home LiteratureArticle Details
PMID: 10606981 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid.

Clinical and experimental immunology ·Vol. 119 ·No. 1 ·2000-01-00 ·Pages 182-8

Bottomley MJ, Webb NJ, Watson CJ, Holt L, Bukhari M, Denton J, Freemont AJ, Brenchley PE

Abstract

The aims of this study were (i) to determine whether PlGF, VEGF and PlGF/VEGF heterodimers are detected in synovial fluid (SF) and plasma samples from patients with a range of arthropathies; (ii) to describe whether any correlation exists between SF PlGF, VEGF and PlGF/VEGF heterodimer levels and the total and differential SF leucocyte counts; and (iii) to investigate the regulation of peripheral blood mononuclear cell (PBMC) VEGF secretion by stimuli relevant to inflammatory joints. PlGF, VEGF and PlGF/VEGF heterodimer levels were measured in the SF and plasma of patients with a range of arthropathies and normal controls by ELISA. Western blotting for PlGF was performed on SF from three patients with rheumatoid arthritis (RA) and primary inflammatory arthropathies. VEGF was quantified in cell culture supernatants after stimulation with lipopolysaccharide (LPS), PlGF or cobalt ions of PBMC isolated from RA patients and controls. PlGF and VEGF were detected in all SF samples. PlGF/VEGF heterodimers were detected in 10.2% of SF samples, most frequently in RA samples. Western blotting confirmed the presence of PlGF in RA SF. PlGF was detected in 52% of RA and 31% of control plasma samples, and VEGF was detected in 38% of RA and 38% of control plasma samples. PlGF/VEGF heterodimers were detected in 21% of RA samples and none of the control samples. In primary inflammatory arthropathy patients, SF PlGF and VEGF levels correlated significantly with the SF total leucocyte count and the neutrophil count. PlGF was the most potent inducer of PBMC VEGF production in both RA and control subjects. This is the first report of the detection of PlGF and PlGF/VEGF heterodimers in the SF of patients with inflammatory arthropathies, and we have shown for the first time that PlGF up-regulates PBMC VEGF production. PlGF may therefore play a key role in the production of VEGF in the inflammatory joint.

MeSH Terms
Adolescent Adult Aged Aged, 80 and over Arthritis/blood,metabolism Case-Control Studies Endothelial Growth Factors/blood,metabolism Female Growth Substances/blood,metabolism Humans In Vitro Techniques Joint Diseases/blood,metabolism Leukocyte Count Leukocytes, Mononuclear/metabolism Lymphokines/blood,metabolism Male Middle Aged Placenta Growth Factor Pregnancy Proteins/blood,metabolism Synovial Fluid/metabolism Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Chemicals
Endothelial Growth Factors Growth Substances Lymphokines PGF protein, human Pregnancy Proteins Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Placenta Growth Factor
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Bottomley M J
Immunology Research, Department of Medicine, University of Manchester, UK.
Webb N J
Watson C J
Holt L
Bukhari M
Denton J
Freemont A J
Brenchley P E
References (38)
38 references, click to expand
  1. Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
    Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2576-81 PMID: 8637916
  2. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.
    Blood. 1996 Apr 15;87(8):3336-43 PMID: 8605350
  3. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Am J Pathol. 1996 Jul;149(1):293-305 PMID: 8686754
  4. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
    J Biol Chem. 1996 Jul 26;271(30):17629-34 PMID: 8663424
  5. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.
    Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1988-92 PMID: 8700872
  6. Cloning and characterization of a novel human gene related to vascular endothelial growth factor.
    Genome Res. 1996 Feb;6(2):124-31 PMID: 8919691
  7. Localisation of placenta growth factor (PIGF) in human term placenta.
    Growth Factors. 1996;13(3-4):243-50,color plates I-II,pre.bk cov PMID: 8919031
  8. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
    Lab Invest. 1997 Apr;76(4):517-31 PMID: 9111514
  9. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D.
    Genomics. 1997 Jun 15;42(3):483-8 PMID: 9205122
  10. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing.
    Biochem Biophys Res Commun. 1997 Jun 27;235(3):493-8 PMID: 9207183
  11. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Oncogene. 1997 Nov 27;15(22):2687-98 PMID: 9400995
  12. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
    Lab Invest. 1998 Jan;78(1):109-16 PMID: 9461127
  13. Human FIGF: cloning, gene structure, and mapping to chromosome Xp22.1 between the PIGA and the GRPR genes.
    Genomics. 1998 Jan 15;47(2):207-16 PMID: 9479493
  14. The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.
    Am J Pathol. 1998 May;152(5):1161-6 PMID: 9588884
  15. Activated human neutrophils express vascular endothelial growth factor (VEGF).
    Cytokine. 1998 Apr;10(4):254-7 PMID: 9617569
  16. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.
    Clin Sci (Lond). 1998 Apr;94(4):395-404 PMID: 9640345
  17. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid.
    Clin Exp Immunol. 1999 Jul;117(1):171-6 PMID: 10403932
  18. In vitro studies of rheumatoid synovium; preliminary metabolic comparison between synovial membrane and villi.
    Br J Exp Pathol. 1955 Apr;36(2):195-8 PMID: 14363583
  19. SEPARATION OF WHITE BLOOD CELLS.
    Nature. 1964 Nov 21;204:793-4 PMID: 14235685
  20. Respiratory gases of synovial fluids. An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis.
    Am J Med. 1970 Aug;49(2):223-31 PMID: 5452943
  21. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
    J Clin Invest. 1989 Nov;84(5):1470-8 PMID: 2478587
  22. Human vascular permeability factor. Isolation from U937 cells.
    J Biol Chem. 1989 Nov 25;264(33):20017-24 PMID: 2584205
  23. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells.
    Biochem Biophys Res Commun. 1991 Dec 16;181(2):902-6 PMID: 1755866
  24. Intra-articular pressure in rheumatoid arthritis of the knee. II. Effect of intra-articular pressure on blood circulation to the synovium.
    Ann Rheum Dis. 1970 May;29(3):266-8 PMID: 5432593
  25. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.
    Science. 1992 Feb 21;255(5047):989-91 PMID: 1312256
  26. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.
    Biochem Biophys Res Commun. 1992 Sep 30;187(3):1579-86 PMID: 1417831
  27. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells.
    J Cell Physiol. 1992 Dec;153(3):557-62 PMID: 1447317
  28. Macrophages and angiogenesis.
    J Leukoc Biol. 1994 Mar;55(3):410-22 PMID: 7509844
  29. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
    J Immunol. 1994 Apr 15;152(8):4149-56 PMID: 7511670
  30. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.
    J Exp Med. 1994 Jul 1;180(1):341-6 PMID: 8006592
  31. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
    J Biol Chem. 1994 Oct 14;269(41):25646-54 PMID: 7929268
  32. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo.
    Lab Invest. 1994 Sep;71(3):374-9 PMID: 7933988
  33. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.
    J Biol Chem. 1995 Mar 31;270(13):7717-23 PMID: 7706320
  34. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability.
    FEBS Lett. 1995 Aug 21;370(3):203-8 PMID: 7656977
  35. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).
    Cell Immunol. 1995 Dec;166(2):196-206 PMID: 7497521
  36. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells.
    J Biol Chem. 1995 Dec 29;270(52):31189-95 PMID: 8537383
  37. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    EMBO J. 1996 Jan 15;15(2):290-98 PMID: 8617204
  38. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    J Biol Chem. 1996 Feb 9;271(6):3154-62 PMID: 8621715
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
2000-01-00
Pages
182-8
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1905543
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com